Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Oct 11;1(1):77-85.
doi: 10.1102/1470-7330/00/010077+09.

Modern surgery for liver metastases

J P Lodge  1
Affiliations

Modern surgery for liver metastases

J P Lodge. Cancer Imaging. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
48% 5-year survival from hepatic resection ( n =161).
Figure 2
Figure 2
58% for bilateral resection ( n =97); 35% for unilobar disease ( n =64) at 5 years ( p > 0.05). This demonstrates that patients with advanced disease can do well.
Figure 1
Figure 1
Metastasis from ovarian cancer. (A) CT showed lesions which are too small to characterize reliably; (B) CT 9 months later showed growth of metastasis.
Figure 2
Figure 2
Colorectal metastases. Arterial phase CT (A) and portal phase CT (B) show a single metastasis. SPIO-enhanced MRI (C) shows an additional 1 cm lesion.
Figure 3
Figure 3
MR technique with SPIO. (A) T2-weighted FSE sequence shows large metastasis in left lobe; (B) optimized gradient echo T2 shows improved contrast between the tumour and normal liver, better visualization of vascular structures, and an additional lesion in segment 8.
Figure 4
Figure 4
Benign liver lesions in a patient with colorectal cancer. (A) TSE T2 image showing 3 cm lesion which was indeterminate on ultrasound, also a second lesion of 7 mm. (B) and (C) T1-weighted image with gadolinium enhancement, arterial phases, showing typical peripheral nodular enhancement in the larger lesion but also an additional hypervascular lesion. Delayed post-gadolinium T1 image showing complete infilling of the 3 cm and 7 mm lesions, typical for haemangioma, and a faint persistent stain in the hypervascular lesion, suggestive of focal nodular hyperplasia. The FNH lesion was undetected on T2-weighted MRI, and also on ultrasound.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Lodge JPA, Ammori BJ, Prasad KR, Bellamy MC. Ex-vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases. Ann Surg. 2000;231:471–9. doi: 10.1097/00000658-200004000-00004. - DOI - PMC - PubMed
    1. Makuuchi M, Hasegawa H, Yamazaki S, Takayasu K. Four new hepatectomy procedures for resection of the right hepatic vein and preservation of the inferior right hepatic vein. Surg Gynecol Obstet. 1987;164:69–72. - PubMed
    1. Ozeki Y, Uchiyama T, Katayama M, et al. Extended left hepatic trisegmentectomy with resection of main right hepatic vein and preservation of middle and inferior right hepatic veins. Surgery. 1995;117:715–7. doi: 10.1016/S0039-6060(95)80018-2. - DOI - PubMed
    1. Belghiti J, Noun R, Zante E, et al. Portal triad clamping or hepatic vascular exclusion for major liver resection: a controlled study. Ann Surg. 1996;224:155–61. doi: 10.1097/00000658-199608000-00007. - DOI - PMC - PubMed
    1. Delva E, Camus Y, Nordlinger B, et al. Vascular occlusions for liver resections — operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg. 1989;209:211–8. doi: 10.1097/00000658-198902000-00012. - DOI - PMC - PubMed
References
    1. Craig JR, Peters RL, Edmondson HA. Tumours of the liver and extrahepatic bile ducts. In: AFIP Atlas of tumour Pathology, Second series fascicle 26, 1989.
    1. Anthony SP, et al. Tumour and tumour-like lesions of the liver and biliary tract. In: MacSween RNM, et al., editors. Pathology of the Liver. 3. Edinburgh: Churchill Livingstone; 1994. pp. 635–711.
    1. Mytiroglou P, Theise ND. Differential diagnosis of hepatocellular nodular lesions. Semin Diagn Pathol. 1998;15:285–99. - PubMed
    1. Schele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal metastasis. World J Surg. 1995;19:59–71. doi: 10.1007/BF00316981. - DOI - PubMed
    1. Yoon SS, Tanebe KK. Multidisciplinary management of metastatic colorectal cancer. Surg Oncol. 1998;7:197–207. doi: 10.1016/S0960-7404(99)00022-5. - DOI - PubMed
References
    1. Blomley M, Cosgrove D. Contrast agents in ultrasound. Br J Hosp Med. 1996;55:6–7. - PubMed
    1. Leen E, McArdle CS. Ultrasound contrast agents in liver imaging. Clin Radiol. 1996;51(Suppl1):35–9. - PubMed
    1. Blomley M, et al. Stimulated acoustic emission imaging (‘sonoscintigraphy’) with the ultrasound contrast agent Levovist: a reproducible Doppler ultrasound effect with potential clinical utility. Acad Radiol. 1998;5(Suppl1):S236–9. doi: 10.1016/S1076-6332(98)80116-5. - DOI - PubMed
    1. Eckersley R. Functional Imaging with ultrasound contrast agents. Ultrasound Med Biol 1999 (in press).
    1. Blomley MJ, et al. Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. Radiology. 1998;209:862–6. doi: 10.1148/radiology.209.3.9844688. - DOI - PubMed
References
    1. Willis RA. The spread of Tumours in the Human Body. 3. London: Butterworths; 1973. Secondary tumours of the liver; pp. 175–83.
    1. Cameron GR. The liver as a site and source of cancer. Br Med J 1954; Feb: 347–52. - PMC - PubMed
    1. Ozarda A, Pickren J. The topographic distribution of liver metastases, its relation to surgical and isotope diagnosis. J Nucl Med. 1962;3:149–52.
    1. Goligher JC. The operability of carcinoma of the rectum. Br Med J. 1941;ii:393–7. doi: 10.1136/bmj.2.4211.393. - DOI - PMC - PubMed
    1. Finlay IG, Meek D, Brunton F, McArdle CS. Growth rate of hepatic metastases in colorectal carcinoma. Br J Surg. 1988;75:641–4. doi: 10.1002/bjs.1800750707. - DOI - PubMed

LinkOut - more resources